Patent Oppositions in digestive drugs industry

Explore the competitive field of digestive drugs where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in digestive drugs technology and learn how to protect your intellectual property.

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the digestive drugs industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the digestive drugs industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Jun 4, 2026
Patent NumberTitleApplicantOpposition DateOpposition Name
Methods Of Treating Fabry Patients Having Renal ImpairmentAMICUS THERAPEUTICSApr 15, 2026BRAND MURRAY FULLER
Oxytocin Receptor Antagonist Therapy In The Luteal Phase For Implantation And Pregnancy In Women Undergoing Assisted Reproductive TechnologiesFERRINGApr 9, 2026JAMES POOLE
New Combination Of Active Agents For The Treatment Of Progressive Fibrosing Interstitial Lung Diseases (Pf-Ild)BOEHRINGER INGELHEIMApr 9, 2026BOTTI & FERRARI
Prebiotic For Treating Disorders Associated With Disturbed Composition Or Functionality Of The Intestinal MicrobiomeNUTRILEADSApr 9, 2026NUTRICIA
New Combination Of Active Agents For The Treatment Of Progressive Fibrosing Interstitial Lung Diseases (Pf-Ild)BOEHRINGER INGELHEIMApr 2, 2026TEVA PHARMACEUTICALS
New Oral Pharmaceutical Composition And Dose Regimen For The Therapy Of Progressive Fibrosing Interstitial Lung DiseasesBOEHRINGER INGELHEIMApr 2, 2026TEVA PHARMACEUTICALS
Pharmaceutical FormulationsARRAY BIOPHARMAMar 18, 2026HAMM & WITTKOPP
Preparation Method For Carotenoid Preparation Having High Bioavailability And High StabilityZHEJIANG MEDICINEMar 17, 2026BASF
Methods Of Treating Conditions Related To The S1P1 ReceptorARENA PHARMACEUTICALSFeb 27, 2026MAIWALD
Combination Therapy For Inhalation AdministrationCHEMO RESEARCHFeb 27, 2026MURGITROYD

To stay ahead in the competitive digestive drugs industry, companies are constantly innovating. Here are the top patents facing oppositions in the digestive drugs industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Jun 4, 2026
Patent NumberPublication DateTitleApplicantTotal Oppositions
Apr 14, 2021Methods And Compositions For Treating CancerJANSSEN ONCOLOGY22
Aug 18, 2021Formulations Of EnzalutamideMEDIVATION PROSTATE THERAPEUTICS12
Dec 11, 2019Pharmaceutical Composition Containing Glycopyrrolate And A Beta2 Adrenoceptor AgonistNOVARTIS10
Nov 14, 2018Therapeutic Uses Of EmpagliflozinBOEHRINGER INGELHEIM8
Dec 11, 2019Methods Of Treating Hepatic EncephalopathySALIX PHARMACEUTICALS8
May 22, 2019Pharmaceutical Formulations Comprising 4-{(1R)-2- [(6-{2-[(2,6-Dichlorobenzyl)Oxy] Ethoxy}Hexyl)Amino]-1-Hydroxyethyl}-2- (Hydroxymethyl)PhenolGLAXO GROUP8
Aug 21, 2024Methods Of Treating New-Onset Plaque Type Psoriasis Using Il-17 AntagonistsNOVARTIS7
Feb 7, 2024Methods For Treating Severe Atopic Dermatitis By Administering An Il-4R InhibitorSANOFI BIOTECHNOLOGY7
Dec 30, 2020Controlled Release Pharmaceutical CompositionASTELLAS PHARMA7
Sep 1, 2021Direct Compression Formulation And ProcessNOVARTIS7